Eli Lilly and Co
Stocks making the biggest moves premarket: Paramount Global, Cava, JD.com and more
Check out the companies making headlines before the bell. Paramount Global — The media conglomerate’s stock dropped nearly 5% after Edgar Bronfman Jr. withdrew his bid for the media company. This clears a path for Skydance Media to take over Shari Redstone’s media empire. Paramount expects the deal with Skydance to close in the first […]
Read More
Eli Lilly releases new form of weight loss drug Zepbound for half the price to boost access, supply
Eli Lilly on Tuesday released a new form of its weight loss drug Zepbound for roughly half its usual monthly list price to reach millions of patients without insurance coverage for the popular injection, such as those with Medicare. The move also aims to expand the supply of Zepbound in the U.S. as demand skyrockets, […]
Read More
CNBC Daily Open: A ‘crazy’ summer
Traders work on the floor of the New York Stock Exchange during morning trading on August 20, 2024 in New York City. Michael M. Santiago | Getty Images This report is from today’s CNBC Daily Open, our international markets newsletter. CNBC Daily Open brings investors up to speed on everything they need to know, no […]
Read More
CNBC Daily Open: ‘Crazy’ summer
Traders work on the floor of the New York Stock Exchange during morning trading on Aug. 20, 2024. Michael M. Santiago | Getty Images This report is from today’s CNBC Daily Open, our international markets newsletter. CNBC Daily Open brings investors up to speed on everything they need to know, no matter where they are. […]
Read More
Stocks making the biggest moves midday: Palo Alto Networks, Boeing, Lowe’s, Bank of America and more
Check out the companies making headlines in midday trading: Bank of America — The bank stock slid 2% after a regulatory filing revealed Warren Buffett’s Berkshire Hathaway is not done downsizing its stake. The conglomerate sold 13.9 million more shares of the bank for $550.7 million over the past three trading days, bringing its stake […]
Read More
Stocks making the biggest premarket moves: Eli Lilly, Paramount Global, Palo Alto Networks and more
Check out the companies making the biggest moves in premarket trading: Eli Lilly — Shares added 1.7% after a late-stage trial found the pharma company’s weight-loss drug tirzepatide, the active ingredient Zepbound and Mounjaro, reduced the risk of obese or overweight adults developing Type 2 diabetes by 94%. Paramount Global — The media and entertainment […]
Read More
Eli Lilly’s weight loss drug slashes the risk of developing diabetes in long-term trial
An Eli Lilly & Co. Zepbound injection pen arranged in the Brooklyn borough of New York, US, on Thursday, March 28, 2024. Shelby Knowles | Bloomberg | Getty Images Eli Lilly’s highly popular weight loss drug reduced the risk of developing Type 2 diabetes by 94% in obese or overweight adults with pre-diabetes compared to […]
Read More
Novo Nordisk vs. Eli Lilly: Analysts weigh in as the obesity-drug battle heats up
COPENHAGEN, Denmark — Analysts are paying close attention to Novo Nordisk and Eli Lilly , as the battle to dominate the weight loss drug market heats up. Europe’s largest company Novo Nordisk has dominated headlines since anti-obesity medication took off. It produces weight-loss and diabetes drugs Wegovy and Ozempic and saw its shares rise exponentially […]
Read More
Biden administration to release prices for first 10 drugs subject to landmark Medicare negotiations
Activists protest the price of prescription drug costs in front of the U.S. Department of Health and Human Services building in Washington, D.C., on Oct. 6, 2022. Anna Moneymaker | Getty Images The Biden administration on Thursday will release prices for the first 10 prescription drugs that were subject to landmark negotiations between drugmakers and […]
Read More
Healthy Returns: Eli Lilly gains momentum against Novo Nordisk in the weight loss drug market
An Eli Lilly & Co. Zepbound injection pen, March 28, 2024. Bloomberg | Bloomberg | Getty Images Think a friend or colleague should be getting this newsletter? Share this link with them to sign up. Good afternoon! Novo Nordisk and Eli Lilly have so far dominated the booming market for a class of weight loss and diabetes drugs. […]
Read More